Open original FDA record ↗Recall record
- FDA identifier
- Z-1942-2010
- Company in FDA record
- Inova Diagnostics Incorporated
- FDA classification date
- Jun 30, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The recall was initiated after the binding site notified Inova Diagnostics, inc. that the affected Bindazyme Human C1q binding Circulating Immune Complex EIA Kits may contain an ELISA plate labeled as "tissue Transglutaminase Coated Wells" instead of "C1q Coated Wells".
Source facts
- Action
- Notification letters from INOVA Diagnostics Incorporated were mailed to each of the consignees via Certified mail on October 30, 2009. The notification letters inform the consignees of the reason for recall and provided instructions for final disposition of the recalled kits. In addition, a FAX back Attachment was attached to the recall notice for customers to respond to the recall.
- Initiated
- 2009-10-28
- Root cause
- Process control
- Terminated
- 2010-06-30
- Distribution
- Worldwide distribution: USA, Germany, Italy, Belgium, Romania, Portugal, Argentina, Spain, Sweden, and India.
- Recall number
- Z-1942-2010
- Recall status
- Terminated
- CDRH record ID
- 91848
- FDA classified
- 2010-06-30
- Recall event number
- 55801